Opportunity, Growth, and the Hidden Risks on the Buy-Side: Investing in Women’s Health

Women’s health is emerging as a compelling—and rapidly evolving—area of investment, driven by innovation, consumer demand, and increased capital flow. As the lines blur between consumer products and regulated healthcare, new complexities are surfacing in diligence and deal execution. This session explores what’s driving momentum, where investors and operators are finding value, and where risk shows up on the buy-side. From product claims and regulatory exposure to transaction liability, learn how experienced dealmakers balance opportunity with discipline.